Mannose Receptor in Ricin Pathogenesis
甘露糖受体在蓖麻毒素发病机制中的作用
基本信息
- 批准号:7876804
- 负责人:
- 金额:$ 17.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-19 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntidotesApoptosisBiological ProductsBiologyBioterrorismBlood CirculationBypassC-Type LectinsCategoriesCell DeathCell surfaceCellsCenters for Disease Control and Prevention (U.S.)CytoplasmCytosolDevelopmentDiseaseDoseEndocytosisEndothelial CellsFunctional disorderGalactoseGlycolipidsGlycoproteinsHepaticHost DefenseHost Defense MechanismImmune systemIn VitroInflammationInstitutesIntoxicationKnock-outKupffer CellsLactoseLectinLinkLiverMannoseMediatingMissionMonoclonal AntibodiesMusNatural ImmunityOrganPathogenesisPathway interactionsPoisoningPopulationProcessProteinsProtocols documentationRibosomesRicinRoleSerumSideSpleenTargeted ToxinsTestingTimeToxic effectToxinUniversitiesViraldesignin vivoinhibitor/antagonistinsightintravenous injectionkillingsmacrophagemannose receptormicroorganism antigenpreventpublic health relevancereceptoruptake
项目摘要
DESCRIPTION (provided by applicant): Ricin is one of the most toxic biological agents known. The proposal will test the hypothesis that the mannose receptor (MR), a C-type lectin normally assumed to function in innate immunity, mediates the uptake of ricin into macrophages in the liver and spleen, and thereby initiates the inflammation and cell death responsible for the earliest and most severe affects associated with ricin poisoning. The hypothesis will be tested using MR knock- out (MR-/-) mice, in conjunction with well-established ricin lethal dose challenge protocols. To determine the effect of the MR in the toxicity of ricin in vivo, Specific Aim 1 will compare the median lethal dose of ricin in wild type and MR-/- mice. Specific Aim 2 will determine the contribution of the MR in clearing ricin from the serum, and targeting the toxin to the liver and spleen. Finally, Specific Aim 3 will identify the role of the MR in mediating toxin-induced apoptosis and inflammation in the spleen and liver. This study is expected to uncover fundamental mechanisms by which pathogenic agents such as ricin toxin exploit the MR to bypass normal host defense mechanisms and gain entry into select sub-populations of host cells. This study will also provide critical information necessary to develop inhibitors of ricin that interfere with the earliest steps in the intoxication process, and will, therefore, advance NIAID's mission to develop effective countermeasures against the Category B Select Agents and Toxins. PUBLIC HEALTH RELEVANCE: Ricin is a deadly toxin that is considered a potential bioterrorism agent by the Centers for Diseases Control and the National Institutes of Heath. This study proposes to investigate how ricin toxin enters into cells and causes disease. The results of this study are expected to yield new insights the design of an effective antidote against this deadly toxin.
描述(申请人提供):蓖麻毒素是已知的毒性最大的生物制剂之一。该提案将检验一种假设,即甘露糖受体(MR)是一种C型凝集素,通常被认为在先天性免疫中起作用,它介导蓖麻毒素进入肝脏和脾的巨噬细胞,从而引发炎症和细胞死亡,导致与蓖麻毒素中毒相关的最早和最严重的影响。这一假设将使用MR基因敲除(MR-/-)小鼠进行验证,并结合公认的蓖麻毒素致死剂量挑战方案。为了确定MR在蓖麻毒素体内毒性中的作用,特异靶1将比较野生型和MR-/-小鼠的蓖麻毒素半数致死剂量。具体目标2将确定MR在清除血清中的蓖麻毒素和将毒素靶向肝脏和脾方面的贡献。最后,特定的目标3将确定MR在介导毒素诱导的脾和肝脏的细胞凋亡和炎症中的作用。这项研究有望揭示蓖麻毒素等病原体利用MR绕过正常宿主防御机制并进入选定的宿主细胞亚群的基本机制。这项研究还将为开发干扰中毒过程中最早步骤的蓖麻毒素抑制剂提供必要的关键信息,因此将推动NIAID开发针对B类精选制剂和毒素的有效对策的使命。与公共健康相关:蓖麻毒素是一种致命的毒素,被疾病控制中心和美国国立卫生研究院认为是一种潜在的生物恐怖分子。这项研究建议调查蓖麻毒素是如何进入细胞并导致疾病的。这项研究的结果有望对这种致命毒素的有效解毒剂的设计产生新的见解。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of the mannose receptor (CD206) in innate immunity to ricin toxin.
- DOI:10.3390/toxins3091131
- 发表时间:2011-09
- 期刊:
- 影响因子:4.2
- 作者:Gage E;Hernandez MO;O'Hara JM;McCarthy EA;Mantis NJ
- 通讯作者:Mantis NJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas J. Mantis其他文献
Collaboration of epithelial cells with organized mucosal lymphoid tissues
上皮细胞与有组织的黏膜淋巴样组织的协作
- DOI:
10.1038/ni1101-1004 - 发表时间:
2001-11-01 - 期刊:
- 影响因子:27.600
- 作者:
Marian R. Neutra;Nicholas J. Mantis;Jean-Pierre Kraehenbuhl - 通讯作者:
Jean-Pierre Kraehenbuhl
Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in contrived dried blood spots and oral fluids
用于在人为干血斑和口腔液中检测 SARS-CoV-2 抗体的微球免疫测定的实验室间协调
- DOI:
10.1128/spectrum.02690-24 - 发表时间:
2025-03-31 - 期刊:
- 影响因子:3.800
- 作者:
Kate L. DeRosa;Nora Pisanic;Kate Kruczynski;Christopher D. Heaney;Linda M. Styer;Nicholas J. Mantis - 通讯作者:
Nicholas J. Mantis
A type-specific B-cell epitope at the apex of outer surface protein C (OspC) of the Lyme disease spirochete, emBorreliella burgdorferi/em
莱姆病螺旋体伯氏疏螺旋体外表面蛋白 C(OspC)顶点的一种特定类型 B 细胞表位
- DOI:
10.1128/spectrum.02883-24 - 发表时间:
2025-02-14 - 期刊:
- 影响因子:3.800
- 作者:
David J. Vance;Grace Freeman-Gallant;Kathleen McCarthy;Carol Lyn Piazza;Yang Chen;Clint Vorauer;Beatrice Muriuki;Michael J. Rudolph;Lisa Cavacini;Miklos Guttman;Nicholas J. Mantis - 通讯作者:
Nicholas J. Mantis
Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in mice
强效和次强效全细胞百日咳疫苗在小鼠中引发的抗体特征
- DOI:
10.1128/spectrum.03253-24 - 发表时间:
2025-03-31 - 期刊:
- 影响因子:3.800
- 作者:
Yetunde Adewunmi;Jennifer Doering;Prashant Kumar;Jozelyn V. Pablo;Andy A. Teng;Vu Huynh;Kathryn Secrist;David B. Volkin;Sangeeta B. Joshi;Joseph J. Campo;Nicholas J. Mantis - 通讯作者:
Nicholas J. Mantis
Nicholas J. Mantis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas J. Mantis', 18)}}的其他基金
Leveraging a transcription regulatory network to understand Salmonella invasion of host epithelial cells
利用转录调控网络了解沙门氏菌对宿主上皮细胞的侵袭
- 批准号:
10154895 - 财政年份:2021
- 资助金额:
$ 17.88万 - 项目类别:
Leveraging a transcription regulatory network to understand Salmonella invasion of host epithelial cells
利用转录调控网络了解沙门氏菌对宿主上皮细胞的侵袭
- 批准号:
10374120 - 财政年份:2021
- 资助金额:
$ 17.88万 - 项目类别:
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
莱姆病:B 细胞表位发现和抗体保护机制
- 批准号:
10677521 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
SARS COV-2 血清学和疫苗学中的高通量干血斑 (HT-DBS) 技术
- 批准号:
10855042 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
莱姆病:B 细胞表位发现和抗体保护机制
- 批准号:
10246232 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
SARS COV-2 血清学和疫苗学中的高通量干血斑 (HT-DBS) 技术
- 批准号:
10222023 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
Tickborne Disease: B cell epitope discovery and mechanisms of antibody Protection
蜱传疾病:B 细胞表位发现和抗体保护机制
- 批准号:
10678249 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
SARS COV-2 血清学和疫苗学中的高通量干血斑 (HT-DBS) 技术
- 批准号:
10688352 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
莱姆病:B 细胞表位发现和抗体保护机制
- 批准号:
10021076 - 财政年份:2019
- 资助金额:
$ 17.88万 - 项目类别:
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
莱姆病:B 细胞表位发现和抗体保护机制
- 批准号:
10912412 - 财政年份:2019
- 资助金额:
$ 17.88万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Continuing Grant